Elijah Frost
Thoracic Surgery (Cardiothoracic Vascular Surgery) Omaha, NE Physician Assistant
NPI 1093449142 CMS profile 11648731
42Nd And Emile, Omaha, NE 68198
General payments
$49
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Elijah Frost of Omaha, NE is reported in the CMS Open Payments database as having received $49 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 4th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $49 | 2 |
Beside peers
- Elijah Frost
- Thoracic Surgery (Cardiothoracic Vascular Surgery) median
- Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
- National median
In program year 2025, general payments to Elijah Frost were reported at $49. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.
Show as a table
| Year | Elijah Frost | Thoracic Surgery (Cardiothoracic Vascular Surgery) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $886 | $178–$3,167 | $163 |
| 2020 | $0 | $341 | $108–$1,605 | $114 |
| 2021 | $0 | $453 | $125–$1,886 | $132 |
| 2022 | $0 | $695 | $180–$2,566 | $149 |
| 2023 | $0 | $745 | $205–$2,662 | $160 |
| 2024 | $0 | $799 | $214–$2,967 | $164 |
| 2025 | $49 | $791 | $208–$3,074 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 5 billing codesPaid by Medicare
$1,321
Medicare patients
15
Services billed
17
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 75% | |
| Osteoporosis | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Nebraska
Helenmari Merritt
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NE
Richard Thompson
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Lincoln, NE
John Batter
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NE
Ryan Shelstad
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Lincoln, NE
Kim Duncan
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NE
David Berkheim
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NE
Related records
Thoracic Surgery (Cardiothoracic Vascular Surgery) in Nebraska
Practitioners in the same specialty and state, ranked by reported value.
All Thoracic Surgery (Cardiothoracic Vascular Surgery)
Everyone recorded under this specialty, nationwide.
Doctors in Nebraska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.